These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17691912)

  • 1. SMILES in QSPR/QSAR Modeling: results and perspectives.
    Toropov AA; Benfenati E
    Curr Drug Discov Technol; 2007 Aug; 4(2):77-116. PubMed ID: 17691912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. QSPR modelling of dielectric constants of π-conjugated organic compounds by means of the CORAL software.
    Achary PG
    SAR QSAR Environ Res; 2014; 25(6):507-26. PubMed ID: 24716837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QSPR modeling of the half-wave potentials of benzoxazines by optimal descriptors calculated with the SMILES.
    Toropov A; Nesmerak K; Raska I; Waisser K; Palat K
    Comput Biol Chem; 2006 Dec; 30(6):434-7. PubMed ID: 17092778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. OCWLGI descriptors: theory and praxis.
    Toropov AA; Toropova AP; Benfenati E; Gini G
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):226-32. PubMed ID: 23700994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR as a random event: modeling of nanoparticles uptake in PaCa2 cancer cells.
    Toropov AA; Toropova AP; Puzyn T; Benfenati E; Gini G; Leszczynska D; Leszczynski J
    Chemosphere; 2013 Jun; 92(1):31-7. PubMed ID: 23566368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. QSPR modeling of octanol/water partition coefficient for vitamins by optimal descriptors calculated with SMILES.
    Toropov AA; Toropova AP; Raska I
    Eur J Med Chem; 2008 Apr; 43(4):714-40. PubMed ID: 17629592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative Structure-activity Relationship Study of Betulinic Acid Derivatives Against HIV using SMILES-based Descriptors.
    Worachartcheewan A; Toropova AP; Toropov AA; Siriwong S; Prapojanasomboon J; Prachayasittikul V; Nantasenamat C
    Curr Comput Aided Drug Des; 2018; 14(2):152-159. PubMed ID: 29332601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. QSAR modelling for mutagenic potency of heteroaromatic amines by optimal SMILES-based descriptors.
    Toropov AA; Toropova AP; Benfenati E
    Chem Biol Drug Des; 2009 Mar; 73(3):301-12. PubMed ID: 19207466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. QSAR models for HEPT derivates as NNRTI inhibitors based on Monte Carlo method.
    Toropova AP; Toropov AA; Veselinović JB; Miljković FN; Veselinović AM
    Eur J Med Chem; 2014 Apr; 77():298-305. PubMed ID: 24657566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified molecular input line entry system-based optimal descriptors: QSAR modelling for voltage-gated potassium channel subunit Kv7.2.
    Achary PG
    SAR QSAR Environ Res; 2014; 25(1):73-90. PubMed ID: 24580100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. coral Software: QSAR for Anticancer Agents.
    Benfenati E; Toropov AA; Toropova AP; Manganaro A; Gonella Diaza R
    Chem Biol Drug Des; 2011 Jun; 77(6):471-6. PubMed ID: 21435183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting normal densities of amines using quantitative structure-property relationship (QSPR).
    Stec M; Spietz T; Więcław-Solny L; Tatarczuk A; Krótki A
    SAR QSAR Environ Res; 2015; 26(11):893-904. PubMed ID: 26524227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMILES-based quantitative structure-property relationships for half-wave potential of N-benzylsalicylthioamides.
    Nesmerak K; Toropov AA; Toropova AP; Kohoutova P; Waisser K
    Eur J Med Chem; 2013 Sep; 67():111-4. PubMed ID: 23850571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support vector machines: development of QSAR models for predicting anti-HIV-1 activity of TIBO derivatives.
    Darnag R; Mostapha Mazouz EL; Schmitzer A; Villemin D; Jarid A; Cherqaoui D
    Eur J Med Chem; 2010 Apr; 45(4):1590-7. PubMed ID: 20110136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting activities without computing descriptors: graph machines for QSAR.
    Goulon A; Picot T; Duprat A; Dreyfus G
    SAR QSAR Environ Res; 2007; 18(1-2):141-53. PubMed ID: 17365965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling anti-HIV compounds: the role of analogue-based approaches.
    Srivastava HK; Bohari MH; Sastry GN
    Curr Comput Aided Drug Des; 2012 Sep; 8(3):224-48. PubMed ID: 22734706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative structure-activity relationship studies of TIBO derivatives using support vector machines.
    Darnag R; Schmitzer A; Belmiloud Y; Villemin D; Jarid A; Chait A; Mazouz E; Cherqaoui D
    SAR QSAR Environ Res; 2010 Apr; 21(3-4):231-46. PubMed ID: 20544549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical graphs, molecular matrices and topological indices in chemoinformatics and quantitative structure-activity relationships.
    Ivanciuc O
    Curr Comput Aided Drug Des; 2013 Jun; 9(2):153-63. PubMed ID: 23701000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CORAL Software: Analysis of Impacts of Pharmaceutical Agents Upon Metabolism via the Optimal Descriptors.
    Toropova MA; Raska I; Toporova AP; Raskova M
    Curr Drug Metab; 2017; 18(6):500-510. PubMed ID: 28260514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of SMILES Notation Based Optimal Descriptors in Drug Discovery and Design.
    Veselinović AM; Veselinović JB; Živković JV; Nikolić GM
    Curr Top Med Chem; 2015; 15(18):1768-79. PubMed ID: 25961525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.